November 07, 2019 at 11:20AM Exemptions and Alternatives

On November 24, 2004, the Food and Drug Administration published a final rule that includes requirements in 21 CFR Part 1271.155 for requesting an exemption from or alternative to any requirement in subpart C (Donor Eligibility) or D (Current Good Tissue Practices) of 21 CFR Part 1271. This rule was

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XEx9rU